Arcadia Biosciences gets Nasdaq notice over $2.5M equity rule shortfall
Nasdaq notified the company it failed the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1), reporting $633,000 as of June 30, 2026. Trading continues on Nasdaq Capital Market.
On August 31, 2026, the company received a Nasdaq notice that it failed to meet the stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1), reporting $633,000 as of June 30, 2026.
Trading continues on the Nasdaq Capital Market, and the company has until October 15, 2026 to s…